1887

Abstract

The defence of a host against viral infections is strongly influenced by cytokines. We investigated the role of the B-cell stimulating cytokines IL-5 and IL-6, and the immuno-suppressive cytokine IL-10, during primary and secondary immune responses in mice against infection with Friend retrovirus (FV) (). IL-5 mice were comparable to C57BL/6 wild-type mice in their ability to control acute FV infection. In contrast, IL-6 and IL-10 mice showed significantly enhanced virus loads in spleen cells. However, this impaired control of acute FV replication did not alter the long-term control over persistent FV in IL-6 and IL-10 mice. Immunization with a live attenuated vaccine virus prior to challenge protected all three types of cytokine-deficient mice from high levels of spleen virus, despite the finding that the vaccinated IL-5- and IL-6-deficient mice had significantly reduced titres of virus-neutralizing IgG class antibodies. The results indicate that IL-6 and IL-10 contribute to primary immune responses against FV, but are dispensable during persistent infection and vaccine-primed secondary responses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-6-1349
2001-06-01
2019-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/6/0821349a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-6-1349&mimeType=html&fmt=ahah

References

  1. Chen, W. F. & Zlotnik, A. ( 1991; ). IL-10: a novel cytotoxic T cell differentiation factor. Journal of Immunology 147, 528-534.
    [Google Scholar]
  2. Chesebro, B., Miyazawa, M. & Britt, W. J. ( 1990; ). Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annual Review of Immunology 8, 477-499.[CrossRef]
    [Google Scholar]
  3. Constant, S. L. & Bottomly, K. ( 1997; ). Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annual Review of Immunology 15, 297-322.[CrossRef]
    [Google Scholar]
  4. Dittmer, U. & Hasenkrug, K. J. ( 2000; ). Different immunological requirements for protection against acute versus persistent Friend retrovirus infections. Virology 272, 177-182.[CrossRef]
    [Google Scholar]
  5. Dittmer, U., Brooks, D. M. & Hasenkrug, K. J. ( 1998; ). Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. Journal of Virology 72, 6554-6558.
    [Google Scholar]
  6. Dittmer, U., Brooks, D. M. & Hasenkrug, K. J. ( 1999a; ). Protection against establishment of retroviral persistence by vaccination with a live attenuated virus. Journal of Virology 73, 3753-3757.
    [Google Scholar]
  7. Dittmer, U., Brooks, D. M. & Hasenkrug, K. J. ( 1999b; ). Requirement for multiple lymphocyte subsets in protection against retroviral infection by a live attenuated vaccine. Nature Medicine 5, 189-193.[CrossRef]
    [Google Scholar]
  8. Dittmer, U., Peterson, K. E., Messer, R., Stromnes, I. M., Race, B. & Hasenkrug, K. J. ( 2001; ). The role of IL-4, IL-12, and IFN-γ in primary and vaccine-primed immune responses to Friend retroviral infection. Journal of Virology 75, 654-660.[CrossRef]
    [Google Scholar]
  9. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. & O’Garra, A. ( 1991; ). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 146, 3444-3451.
    [Google Scholar]
  10. Hasenkrug, K. J. ( 1999; ). Lymphocyte deficiencies increase susceptibility to Friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. Journal of Virology 73, 6468-6473.
    [Google Scholar]
  11. Hasenkrug, K. J. & Chesebro, B. ( 1997; ). Immunity to retroviral infection: the Friend virus model. Proceedings of the National Academy of Sciences, USA 94, 7811-7816.[CrossRef]
    [Google Scholar]
  12. Hasenkrug, K. J. & Dittmer, U. ( 2000; ). The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model. Virology 272, 244-249.[CrossRef]
    [Google Scholar]
  13. Hasenkrug, K. J., Brooks, D. M. & Chesebro, B. ( 1995; ). Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proceedings of the National Academy of Sciences, USA 92, 10492-10495.[CrossRef]
    [Google Scholar]
  14. Hasenkrug, K. J., Brooks, D. M. & Dittmer, U. ( 1998a; ). Critical role for CD4+ T cells in controlling retrovirus replication and spread in persistently infected mice. Journal of Virology 72, 6559-6564.
    [Google Scholar]
  15. Hasenkrug, K. J., Brooks, D. M., Robertson, M. N., Srinivas, R. V. & Chesebro, B. ( 1998b; ). Immunoprotective determinants in Friend murine leukemia virus envelop protein. Virology 248, 66-73.[CrossRef]
    [Google Scholar]
  16. Hoatlin, M. E. & Kabat, D. ( 1995; ). Host-range control of a retroviral disease: Friend erythroleukemia. Trends in Microbiology 3, 51-57.[CrossRef]
    [Google Scholar]
  17. Kabat, D. ( 1989; ). Molecular biology of Friend viral erythroleukemia. Current Topics in Microbiology and Immunology 148, 1-42.
    [Google Scholar]
  18. Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt-Lindqvist, S., Takahashi, M. and others ( 1986; ). Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324, 70–73.[CrossRef]
    [Google Scholar]
  19. Kishimoto, T. ( 1989; ). The biology of interleukin-6. Blood 74, 1-10.
    [Google Scholar]
  20. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. & Kohler, G. ( 1994; ). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339-342.[CrossRef]
    [Google Scholar]
  21. Kopf, M., Brombacher, F., Hodkin, P. D., Ramsay, A. J., Milbourne, E. A., Dai, W. J., Ovington, K. S., Behm, C. A., Köhler, G., Young, I. G. & Matthaei, K. I. ( 1996; ). IL-5 deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24.[CrossRef]
    [Google Scholar]
  22. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. ( 1993; ). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.[CrossRef]
    [Google Scholar]
  23. LeBlanc, R. A., Pesnicak, L., Cabral, E. S., Godleski, M. & Straus, S. E. ( 1999; ). Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. Journal of Virology 73, 8145-8151.
    [Google Scholar]
  24. Lin, M. T., Hinton, D. R., Parra, B., Stohlman, S. A. & van der Veen, R. C. ( 1998; ). The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245, 270-280.[CrossRef]
    [Google Scholar]
  25. Miyazawa, M., Nishio, J. & Chesebro, B. ( 1992; ). Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene. Journal of Virology 66, 4497-4507.
    [Google Scholar]
  26. Moore, K. W., O’Garra, A., de Waal Malefyt, R., Vieira, P. & Mosmann, T. R. ( 1993; ). Interleukin-10. Annual Review of Immunology 11, 165-190.[CrossRef]
    [Google Scholar]
  27. Moreau-Gachelin, F., Tavitian, A. & Tambourin, P. ( 1988; ). Spi-1 is a putative oncogene in virally induced murine erythroleukemia. Nature 331, 277-280.[CrossRef]
    [Google Scholar]
  28. Munroe, D. G., Peacock, J. W. & Benchimol, S. ( 1990; ). Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Molecular and Cellular Biology 10, 3307-3313.
    [Google Scholar]
  29. Persons, D. A., Paulson, R. F., Loyd, M. R., Herley, M. T., Bodner, S. M., Bernstein, A., Correll, P. H. & Ney, P. A. ( 1999; ). Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nature Genetics 23, 159-165.[CrossRef]
    [Google Scholar]
  30. Peterson, K. E., Iwashiro, M., Hasenkrug, K. J. & Chesebro, B. ( 2000; ). Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4+ and CD8+ T cells important for recovery from Friend retrovirus-induced leukemia. Journal of Virology 74, 5363-5367.[CrossRef]
    [Google Scholar]
  31. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Koehler, G. & Kopf, M. ( 1994; ). The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561-563.[CrossRef]
    [Google Scholar]
  32. Ramshaw, I. A., Ramsay, A. J., Karupiah, G., Rolph, M. S., Mahalingam, S. & Ruby, J. C. ( 1997; ). Cytokines and immunity to viral infections. Immunological Review 159, 119-135.[CrossRef]
    [Google Scholar]
  33. Robertson, M. N., Spangrude, G. J., Hasenkrug, K., Perry, L., Nishio, J., Wehrly, K. & Chesebro, B. ( 1992; ). Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice. Journal of Virology 66, 3271-3277.
    [Google Scholar]
  34. Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P. & Cannon, M. J. ( 2000; ). Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD+ cytotoxic T lymphocytes. Journal of Virology 74, 4729-4737.[CrossRef]
    [Google Scholar]
  35. Super, H. J., Brooks, D., Hasenkrug, K. J. & Chesebro, B. ( 1998; ). Requirement for CD4+ T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice. Journal of Virology 72, 9400-9403.
    [Google Scholar]
  36. Wendling, F. & Tambourin, P. E. ( 1978; ). Oncogenicity of Friend-virus-infected cells: determination of origin of spleen colonies by the H-2 antigens as genetic markers. International Journal of Cancer 22, 479-486.[CrossRef]
    [Google Scholar]
  37. Yokota, T., Coffman, R. L., Hagiwara, H., Rennick, D. M., Takebe, Y., Yokota, K., Gemmell, L., Shrader, B., Yang, G., Meyerson, P. and others ( 1987; ). Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5. Proceedings of the National Academy of Sciences, USA 84, 7388–7392.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-6-1349
Loading
/content/journal/jgv/10.1099/0022-1317-82-6-1349
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error